CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

Complete Revascularization Versus Culprit Lesion Only in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: A DANAMI-3-PRIMULTI Cardiac Magnetic Resonance Substudy 2-Year Outcomes After Stenting of Lipid-Rich and Nonrich Coronary Plaques Clopidogrel or ticagrelor in acute coronary syndrome patients treated with newer-generation drug-eluting stents: CHANGE DAPT Qualitative Methodology in Cardiovascular Outcomes Research: A Contemporary Look When high‐volume PCI operators in high‐volume hospitals move to lower volume hospitals—Do they still maintain high volume and quality of outcomes? Microthrombi As A Major Cause of Cardiac Injury in COVID-19: A Pathologic Study Efficacy and safety of rosuvastatin vs. atorvastatin in lowering LDL cholesterol : A meta-analysis of trials with East Asian populations Association between urinary dickkopf-3, acute kidney injury, and subsequent loss of kidney function in patients undergoing cardiac surgery: an observational cohort study ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization: A Report by the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology Endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed Tomography Management of two major complications in the cardiac catheterisation laboratory: the no-reflow phenomenon and coronary perforations

Original Research2022 Mar 8;11:e70240.

JOURNAL:Elife. Article Link

Gut microbiota induces high platelet response in patients with ST segment elevation myocardial infarction after ticagrelor treatment

X Zhang, XL Zhang, YL Han et al. Keywords: gut microbiota; HPR; ticagrelor

Full Text PDF